肝素对肝素结合蛋白的血度的影响:一个试点研究
Halla Halldorsdottir1,2, Lennart Lindbom2, Anette Ebberyd2
1Department of Clinical Sciences, Division of Anaesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden.
BJA open
|February 6, 2024
概括
氨酸的使用显著增加了中性粒细胞衍生的氨酸结合蛋白 (HBP) 水平,以剂量依赖的方式. 低分子量肝素 (LMWH) 也会提高HBP,但在较小的程度上.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 中性粒细胞衍生的肝素结合蛋白 (HBP) 在炎症期间与内皮功能障碍有关.
- 乙型肝炎是器官功能障碍和败血症疾病进展的潜在预测因素.
研究的目的:
- 为了研究肝素给药对手术患者血HBP度的影响.
- 评估不同类型的肝素对HBP水平的剂量依赖性影响.
主要方法:
- 三组患者接受了不同剂量的肝素 (血管,心脏,用LMWH进行整体手术).
- 使用ELISA和FIC-Q100方法测量了系列血HBP度.
- 在心脏手术组中,骨髓氧化酶和综-1水平也被分析.
主要成果:
- 氨酸诱导了血管和心脏手术患者的血HBP的快速,剂量依赖的增加.
- 服用LMWH导致HBP显著增加,尽管明显程度较低.
- 血髓氧化酶在肝素后也迅速增加,这与syndecan-1不同.
- 两种HBP测定方法显示出强烈的相关性 (r=0.94).
结论:
- 在肝素给药后,血HBP度迅速且依剂量上升.
- 皮下LMWH会增加血HBP,但比未分离的肝素要少一些.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Hepatic Drug Clearance: Effect of Protein Binding
198
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
198
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K
Factors Affecting Protein-Drug Binding: Drug Interactions
140
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
140
Protein-Drug Binding: Mechanism and Kinetics
483
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
483
Factors Affecting Protein-Drug Binding: Protein-Related Factors
160
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
160


